Overview of the CNS pharmacology of BW 1370U87: A chemically novel, reversible, selective MAO-A inhibitor with potential to be a new antidepressant drug-Reference-Cited by-同舟云学术

Overview of the CNS pharmacology of BW 1370U87: A chemically novel, reversible, selective MAO-A inhibitor with potential to be a new antidepressant drug

Published:1992 Issue:3 Volume:25 Page:181-190
ISSN:0272-4391
Container-title:Drug Development Research
language:en
Short-container-title:Drug Dev. Res.

Author:

Cooper B. R.,White H. L.,Beek O.,Norton R. M.,Rigdon G. C.,Howard J. L.,Kraemer G. W.,Ferris R. M.

Publisher

Wiley

Subject

Drug Discovery

Reference32 articles.

1. The Monoamine Oxidase Inhibitor-Tyramine Interaction

2. Potentiation of the behavioral effects of 5-hydroxytryptophan by BW 1370U87, a selective monoamine oxidase-A inhibitor

3. Blood pressure effects of monoamine oxidase inhibitors in response to orally administered tyramine in the rat

4. Effect of central catecholamine alterations by 6-hydroxydopamine on shuttle box avoidance acquistion

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of monoamine oxidase–A activity in rat brain by synthetic hydrazines: Structure-activity relationship (SAR);Journal of Enzyme Inhibition and Medicinal Chemistry;2005-06

2. On the role of monoamine oxidase-A for the maintenance of the volitional consumption of ethanol in two different rat models;Naunyn-Schmiedeberg's Archives of Pharmacology;2002-10-01

3. Behavioral and Biochemical Studies of Dichloromethane Fraction From the Areca catechu Nut;Pharmacology Biochemistry and Behavior;2000-01

4. Efficacy of Succimer Chelation for Reducing Brain Lead in a Primate Model of Human Lead Exposure;Toxicology and Applied Pharmacology;1999-12

5. 2,8-Dimethylphenoxathiin 10-Oxide;Acta Crystallographica Section C Crystal Structure Communications;1998-10-15